trending Market Intelligence /marketintelligence/en/news-insights/trending/rHLmbI97cAj7dHO-MlqWqA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Ablynx establishes US subsidiary

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Ablynx establishes US subsidiary

Ablynx NV established Ablynx Inc., a subsidiary in the U.S.

Daniel Schneider will head the unit as general manager with the goal of commercializing caplacizumab in North America.

If approved by regulatory authorities, caplacizumab would be the first therapeutic specifically indicated to treat acquired thrombotic thrombocytopenic purpura.